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Abstract – African horse sickness virus (AHSV) is an orbivirus that is usually transmitted between its
equid hosts by adult Culicoides midges. In this article, we review the ways in which AHSV may have
adapted to this mode of transmission. The AHSV particle can be modiﬁed by the pH or proteolytic
enzymes of its immediate environment, altering its ability to infect different cell types. The degree of
pathogenesis in the host and vector may also represent adaptations maximising the likelihood of
successful vectorial transmission. However, speculation upon several adaptations for vectorial
transmission is based upon research on related viruses such as bluetongue virus (BTV), and further
direct studies of AHSV are required in order to improve our understanding of this important virus.
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African horse sickness virus (AHSV) is an
orbivirus transmitted between equid hosts by
Culicoides midges (Diptera, Ceratopogonidae).
The clinical signs of AHSV infection are rarely
seen in zebras and donkeys, but mortality rates
can exceed 90% in horses. Although largely
restricted to sub-Saharan Africa, AHSV has
expanded beyond this core region on several
occasions [24, 36], and has persisted for several
years on each, suggesting that the geographical
area that is potentially suitable for its transmis-
sion is considerably greater than that in which it
currentlyoccurs.Asaconsequenceofitsseverity
in horses and its proven capacity for sudden and
rapidexpansion,Africanhorsesickness(AHS)is
listed by the OIE as a notiﬁable disease.
Historical distribution and major outbreaks
– Despite occasional small outbreaks in North
Africa and the Arabian Peninsula, prior to
1959 AHSV was thought to be effectively con-
ﬁned to sub-Saharan Africa [75, 91]. During
that year, AHSV-9 emerged in the Middle East,
spreading as far as Pakistan and India [29, 36,
37, 75, 91]. This devastating outbreak caused
the deaths of over 300 000 equids before mas-
sive vaccination and vector control efforts,
combined with the virtual extinction of suscep-
tible hosts in the region, brought it to a halt in
1961 [4, 64]. Another outbreak caused by the
same serotype occurred in North Africa during
1965, and is thought to have originated from
infected donkeys that were transported across
the Sahara. This outbreak brieﬂy spread as far
north as southern Spain [23, 24, 43, 76]. In
1987, AHSV-4 was accidentally introduced into
central Spain when infected zebras were
imported for a safari park near Madrid [47],
and remained active on the Iberian peninsula
until 1990. More recently, in 2007, AHSV-4
was detected in Kenya and AHSV-2 and
AHSV-7 were both detected in Senegal
1,a
country where serotype 9 has previously been
detected [82]. This was the ﬁrst time AHSV-2
or AHSV-7 had been detected in West Africa.
During 2007 the virus was also detected in
Nigeria, Ghana, Mali and Mauritania.
Orbiviruses have spread from West Africa to
the Iberian Peninsula on several occasions,
probably via the transportation of infected adult
Culicoides on the wind [1, 95, 96]. The circula-
tionofAHSVin WestAfrica, combinedwiththe
rapid emergence of bluetongue virus (BTV) in
Europe since 1998, and particularly the damage
causedbyBTV-8since2006[114],suggeststhat
the potential for Culicoides-borne orbiviruses to
spread in Europemaybegreater than previously
appreciated. The recent spread of multiple
AHSV serotypes to West Africa has further
increasedthe riskof its introduction into Europe.
In light of both these developments, an
improved understanding of factors that can
inﬂuence the distribution and spread of AHSV
is urgently required. This paper reviews the
ways in whichAHSVis adapted tovector-borne
transmission.
2. THE AHSV TRANSMISSION CYCLE
2.1. The transmission of vector-borne diseases
AHSVisa memberofthe genusOrbivirusin
the family Reoviridae [74, 98, 99, 108]. The
orbiviruses are predominantly transmitted via
the bites of haematophagous arthropods, the
main vectors being Culicoides midges, ticks,
phlebotomine sandﬂies and mosquitoes [17,
67], whiletheir vertebrate hostsinclude bats,eq-
uids,primates,ruminants,lagomorphs,andbirds
[17, 30]. The biological transmission of AHSV
by Culicoides vectors is illustrated in Figure 1.
For biological transmission by haematopha-
gous arthropods, the virus must be present in
peripheral blood vessels or in the skin tissues
of the vertebrate host, making it accessible to
blood-feeding arthropods. It must then survive
in the environment of the arthropod gut long
enough to penetrate and infect the cells of the
gut wall. It must then ﬁnally spread through
the internal environment of the arthropod to
infect the salivary glands in order to be trans-
mitted back to the vertebrate host during sub-
sequent blood-feeding. The time between
1 http://www.reoviridae.org/dsRNA_virus_proteins/
outbreaks.htm/
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the virus to another vertebrate host is termed
the extrinsic incubation period (EIP), and is
dependent upon the temperature experienced
by the arthropod vector. In order for an infected
arthropod to act as an effective vector, the virus
must avoid causing signiﬁcant pathogenesis
during this stage, and the virus must also retain
the ability to replicate in the vertebrate host.
Consequences for genetic diversity –T h e
evolution and adaptation of vector-borne patho-
gens such as AHSVis constrained by a require-
ment to maintain viability under different
conditions and retain the ability to infect very
diverse cells within their mammalian hosts and
arthropodvector species [20,31].However, var-
iant genotypes inevitably arise during the pro-
cesses of genome transcription and virus
replication, while the small quantities of virus
thatareingestedandtransmittedbysmallinsects
such as Culicoides represent a bottleneck that is
likely to select a subset of the viral quasispecies
present. This may lead to a particular variant or
subpopulation becoming established as a novel
genotype, a process that has been observed for
BTV [13], and this ‘‘founder effect’’ is likely
to play a signiﬁcant role in establishing the
genetic diversity of Culicoides-borne orbivirus-
es in the face of evolutionary constraints.
Differences in cell and organ tropism, as well
as antigenic selective pressure, may also help
to determine the likelihood of certain strains
being transmitted. This possibility is explored
further in Section 3.2.
The infection of a host cell by two or more
differentstrainsbelongingtothe sameOrbivirus
species is likely to result in the generation of
progeny viruses containing genome segments
derived from both parental strains [72].
Reassortment is unique to segmented viruses
such as AHSV, and provides a rapid mechanism
forthegenerationofgeneticdiversityandsubse-
quent virus evolution. Reassortment of RNA
segments between orbivirus strains has been
reported in vertebrate hosts, in insect vectors
and in cell cultures [81, 94], with data suggest-
ing that the rate of reassortment is higher in
the insect (42%) than in the vertebrate host
(5%).
Reassortment between different co-circulat-
ing viruses provides a mechanism allowing
individual genome segments which confer a
selective advantage within a particular ecosys-
tem to rapidly spread and become established
within the local virus population. Although rel-
atively few sequence data are currently avail-
able for AHSV genome segments
2,t h e
global distribution of BTV is reﬂected by sig-
niﬁcant sequence variations in each of its gen-
ome segments between viruses from different
geographic regions (e.g. the eastern and western

















Figure 1. The AHSV transmission cycle. (A color version of this ﬁgure is available at www.vetres.org.)
2 http://www.reoviridae.org/dsRNA_virus_proteins
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ment in the ﬁeld and the establishment of
speciﬁc variants of individual genome segments
within a virus population are known for BTV
[8]. These regional BTV variants are likely to
have become established by reassortment, and
as the geographical distribution of AHSV
expands, the same mechanism may result in
the rapid development of regional AHSV
variants.
2.2. Primary and secondary vector species
2.2.1. Culicoides vectors of AHSV
AHSV is transmitted primarily by the bites
of adult female Culicoides midges, which feed
on blood to provide a protein source for egg
production. Approximately 30 of the over 1500
identiﬁed species of Culicoides are believed to
be capable of orbivirus transmission. The most
important vector of AHSV in the ﬁeld is
Culicoides imicola, a species common through-
out Africa and South East Asia. Although
C. imicola was not identiﬁed in southern
Europe until 1982 [14], earlier AHS outbreaks
[23] suggest that it was probably already pres-
ent in the region. C. imicola breeds in damp,
organically enriched soil, and the adults feed
opportunistically upon equids, ruminants
and pigs [77]. In the AHSV-endemic areas of
southern Africa, C. imicola typically accounts
f o r>9 0 %o ft h eCulicoides collected during
light-trap surveillance in locations where
AHSV (or BTV) are endemic, although it is less
common in cooler highland regions [105]. The
adult insects appear to be reluctant to enter
enclosed buildings [85].
These characteristics of C. imicola have sig-
niﬁcant consequences for the epidemiology of
imicola-transmitted AHSV. The nature of
breeding sites suitable for C. imicola means that
they are largely dependent on the level of rain-
fall, and heavy rains can signiﬁcantly increase
the abundance of adult Culicoides, in some
cases up to 200-fold [59]. Major epizootics of
AHS in South Africa are strongly associated
with periods of heavy rain that are preceded
by drought, a situation that also encourages sus-
ceptible hosts to congregate at watering holes,
amplifying transmission further. These weather
patterns are more common during the El Nin ˜o
phase of the El Nin ˜o Southern Oscillation,
and a statistical association between the latter
and the occurrence of AHS outbreaks has been
identiﬁed [9]. However, the relatively broad
range of species targeted by C. imicola means
that a proportion of infectious vectors will bite
animals that are not susceptible to AHSV. The
reluctance of C. imicola to enter enclosed
spaces has also led to the widespread belief that
stabling animals can substantially reduce
AHSV transmission [85]. Recent work has
implicated a second African species, Culicoides
bolitinos, as a potential vector of AHSV [61].
C. bolitinos is morphologically very similar to
C. imicola, and was only identiﬁed as a separate
species in 1989 [58]. This species is widely dis-
tributed in southern Africa and is particularly
common in the cooler highland areas, where
C. imicola is rare [61, 106]. C. bolitinos is also
less reluctant to enter animal housing,
potentially reducing the effectiveness of
stabling as a method of limiting transmission
in regions where it is a signiﬁcant vector
species [60].
Morphological similarities between adult
Culicoides have hampered the identiﬁcation of
the European vectors of AHSV. Members of
the Culicoides obsoletus and Culicoides pulic-
aris groups typically make up > 90% of the
individuals collected during light-trap surveil-
lance in northern Europe, and during the
Spanish outbreak of AHS in 1987–1990,
AHSV was isolated from mixed insect ‘‘pools’’
consisting almost entirely of midges from these
Culicoides groups [63]. More recently, the
C. obsoletus and C. pulicaris groups have also
been implicated as European vectors of BTV
[18]. However, the obsoletus group contains
several distinct but morphologically indistin-
guishable species, which are likely to exhibit
differences in their behaviour and vector capac-
ity for these orbiviruses. Molecular techniques
have recently been developed that can be used
to distinguish individual species within each
Culicoides group [55, 79], which will facilitate
further studies of their vector competence.
The North American bluetongue vector
Culicoides sonorensis can also be infected with
Vet. Res. (2009) 40:16 A. Wilson et al.
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2.2.2. Secondary vector species
AHSV infection and transmission have been
shown in some species of mosquitoes in the
laboratory [15, 64, 84], but they are generally
considered to be of minor (if any) epidemiolog-
ical signiﬁcance as vectors in the ﬁeld [15, 65,
84]. AHSV has also been isolated from ﬁeld
samples of Hyalomma dromadarii ticks in
Egypt
3,4, and further experiments demonstrated
the possibility of transmission by this species to
susceptible horses [5]. Since ticks have a rela-
tively long lifespan compared to mosquitoes
and Culicoides, it is possible that they could
provide an effective reservoir for AHSV. How-
ever, as these experiments have not been
repeated or conﬁrmed, the role of ticks in the
epidemiology of AHS remains uncertain,
although most scientiﬁc opinion suggests that
any role is likely to be small.
2.3. Primary and secondary host species
AHSV is capable of infecting all equids (i.e.
horses, donkeys, asses and zebras). Zebra spe-
cies are generally considered to be the natural
vertebrate host, but rarely display clinical signs
of infection. Historically, endemic transmission
of the virus was thought to be limited to regions
where zebra species occur. However, AHS epi-
zootics have also occurred beyond the distribu-
tion of zebra species, in India and the Middle
East, as well as in North Africa and the Iberian
Peninsula, during 1959–1961, 1965–1966 and
1987–1990, caused by AHSV-9 and AHSV-4.
Together with the continuing circulation of the
virus (AHSV-2 and AHSV-7) in West Africa,
this suggests that although zebra may represent
important reservoir hosts, maintaining the virus
in the ﬁeld, they are not an essential part of the
virus replication and transmission cycles. In
view of the recent and rapid spread of BTV
across Europe, this suggests that the distribution
of AHSV also has the potential to expand dra-
matically in the near future, with devastating
results.
The introduction of horses into central and
east Africa during the 16th century resulted in
the ﬁrst detailed observations of AHS [102]
and regular outbreaks have been reported from
sub-Saharan Africa ever since. However, the
frequency and extent of these outbreaks has
declined over the last century, possibly as a
result of the decline in wild zebra populations
[68]. The extremely high mortality rate seen
in horses limits the extent to which endemic
transmission can occur in the species, and is
b e l i e v e dt oh a v eb e e nam a j o rf a c t o ri nb r i n g i n g
about the end of the 1959–1961 outbreak of
AHSV-9 [4, 64]. It may also help to explain
why the presence of an asymptomatic reservoir
host such as zebra is an important factor for the
endemic circulation of AHSV in the ﬁeld. The
AHSV viraemic period is considerably longer
in zebras than in horses, and the decision to
base quarantine regulations on the duration of
viraemia in the latter was one of the causes of
the accidental introduction of AHSV into Spain
in 1987 [6].
In addition to equids, AHSV can infect cer-
tain carnivores via the ingestion of infected
meat [2]. Antibodies to ﬁve different serotypes
of AHSV have been detected in African carni-
vores [2], although these differed from those
serotypes known to be circulating in the region
at the time. Dogs infected with AHSV are
capable of developing severe clinical disease,
usually of the pulmonary kind, and frequently
die from the infection. This pathology suggests
that dogs develop AHSV viraemia, although
its titre and duration are uncertain. However,
AHSV transmission from a carnivore (dog,
wild dog or big cat) has not been documented
in the wild, and it is not known how fre-
quently the Culicoides vectors of AHSV bite
dogs, if at all. The role of carnivores in the
transmission cycle of AHS therefore remains
unclear, but it is considered likely that they
3 Salama S.A., El-Husseini M.M., Abdulla S.K.,
Isolation and identiﬁcation of African horse sick-
ness virus in the camel tick, 3rd Annual Report, US
AHS project Cairo, 1979.
4 Salama S.A., El-Husseini M.M., Abdulla S.K.,
Isolation and identiﬁcation of African horse sick-
ness virus in the camel tick, 4th Annual Report, US
AHS project Cairo, 1980.
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of infection. AHSV antibodies have also been
reported in elephants [11].
2.4. Virus structure and protein function
Like other orbiviruses, AHSV has a genome
consisting of 10 segments of double-stranded
RNA, which encode seven structural proteins
(VP1–VP7) and four nonstructural proteins
(NS1,NS2,NS3andNS3a)[74].TheRNAgen-
ome is surrounded by the virus core, composed
of an innermost ‘‘subcore’’ layer consisting of
120 copies of the VP3 protein, associated with
minor structural proteins VP1, VP4 and VP6
[32]. The outer surface of the core is composed
of 780 copies of VP7, which helps to stabilise
the subcore layer [69]. In intact virus particles,
this virus core is itself enclosed within an outer
capsid of VP2 and VP5 trimers. This structure
is shown in Figure 2.
Components of the outer capsid layer can be
released from the AHSV core below pH 6. This
is thought to occur in vivo within endosomes
during the processes of infection and cell entry,
activating the transcriptase activity of the virus
core, which is released into the host-cell cyto-
plasm. Cleavage of VP2 in the AHSV outer
capsid by trypsin or chymotrypsin generates
infectious subviral particles (ISVP) [16]. The
epidemiological signiﬁcance of ISVP is
discussed in Section 3.1.
The AHSV outer capsid proteins (VP2 and
VP5) mediate cell attachment and penetration
during the early stages of infection in mamma-
lian cells. These proteins also determine the
range of host cell types which the virus is able
to infect, thereby inﬂuencing the sites of virus
replication and tissues in which the virus is con-
centrated. Phylogenetic analyses have shown
that the outer capsid proteins of BTV and
epizootic haemorrhagic disease of deer virus
are more closely related to each other than to
those of AHSV [74], despite the overlapping
geographic distribution of all three viruses. This
may reﬂect adaptation to their respective hosts
[112]. These proteins also determine the
speciﬁcity of interactions between neutralising
antibodies and the AHSV particle, and conse-
quently control virus serotype [10, 21, 22, 49,
Figure 2. Diagram of orbivirus structure. Figure published in Virus Taxonomy: VIIIth Report of the
International Committee on Taxonomy of Viruses, Mertens P.P.C., Attoui H., Duncan R., Dermody T.S.
(Eds.), Reoviridae, pp. 447–454,  Elsevier. (A color version of this ﬁgure is available at www.vetres.org.)
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proteins show substantial genetic variation,
and the VP2 gene is the most variable segment
of the orbivirus genome [49, 50]. Although
VP2 is thought to contain most of the major
serotype-determining antigens of AHSV, VP5
can also induce low levels of neutralising anti-
bodies in the absence of VP2 [54].
VP7 forms the surface layer of the AHSV
core. The ﬁnding that BTV core particles have
a similar speciﬁc infectivity to that of intact
virus particles for insect cells, but a drastically
reduced infectivity for mammalian cells, sug-
gests that core particles can also achieve cell
attachment and entry of the virus in insect sys-
tems [117], possibly involving a distinct cell
surface receptor from that used by VP2. How-
ever the increased infectivity of ISVP for adult
Culicoides and insect cell cultures, compared to
intact virus particles, suggests that they repre-
sent the primary route of infection in the vector
insect.
The AHSV nonstructural proteins can be
detected in the cytoplasm and membranes of
infected cells [100]. NS1 forms tubular struc-
tures within the cell cytoplasm, while NS2 is a
major component of the granular viral inclusion
bodiesthatformwithinthecytoplasmofinfected
cells.NS3canbecome glycosylatedand isincor-
porated into the cell surface membrane. These
NS proteins are believed to facilitate the pro-
cessesofvirusreplicationandcellexit.Theirrel-
evance in the context of adaptation to vectorial
transmission is discussed in Section 4.1.
The AHSVNS3gene is thesecondmost var-
iable after the segment encoding VP2 [104],
although this is not true of all orbiviruses [50].
Because NS3 is associated with the membrane
of infected cells and it is relatively exposed to
the host immune system, its high variability
may be partially due to selective pressure to
avoidimmunerecognition[90].However,based
on ﬁndings in BTV, it has also been suggested
that variability in nature of VP7 and NS3 may
be partly due to their roles in the infection and
release of virus particles from insect cells, and
thatthisvariabilitycorrespondstogenetic differ-
ences in the insects that the virus infects [50].
The remaining proteins (VP1, VP3, VP4 and
VP6) are components of the virus subcore and
appear to be largely concerned with the funda-
mental organisation, transcription, capping rep-
lication and packaging of the viral RNAs. They
play a fundamental role in virus replication in
both insect and mammalian cells, and may
show variations or adaptations that are involved
in transmission by the insect vector. For exam-
ple, the activity of VP1, the RNA-dependent
RNA polymerase, is highly dependent upon
temperature, with an optimum between 27
and 42 C, and little or no activity below
12–15 C. Since insect vectors are ectothermic,
the rate of viral RNA synthesis and therefore
replication within the vector is largely governed
by ambient temperature [115]. Variation in the
genome segment coding for VP1 could there-
fore have important consequences for the geo-
graphic and seasonal distribution of AHSV
transmission, inﬂuencing the duration and cir-
cumstances under which the EIP can be com-
pleted. This is discussed further in Section
4.2. However, all the core structural proteins
are very highly conserved [50] and as a result
are considered relatively unlikely to play a sig-
niﬁcant role in speciﬁc adaptation of the virus
to vectorial transmission.
Variations in VP1, VP2, VP5, VP7 and
nonstructural proteins NS1 and NS3 are con-
sidered most likely to inﬂuence the range of
host and vector cell-types that can be infected
by a speciﬁc orbivirus, the environmental
conditions required for replication and trans-
mission, the degree of pathogenesis resulting
from infection, and the identity of the virus
from the perspective of the vertebrate immune
system. Adaptation of the virus for vectorial
transmission is therefore likely to be largely
restricted to the genome segments coding
for these proteins.
3. ADAPTATION FOR TRANSMISSION
FROM HOST TO VECTOR
3.1. Generation of ISVP
The exposure of intact AHSV particles to
serine proteases results in the cleavage of
VP2, generating two or more cleavage products
that remain associated with the outer capsid
AHSV adaptations for vector transmission Vet. Res. (2009) 40:16
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has a similar infectivity for mammalian
cell lines but greatly enhanced infectivity for
C. sonorensis tissue culture cells (KC cells)
[70]. BTV is also capable of forming ISVP
[73]. Results obtained by immunogold labelling
of BTV virus particles, by monoclonal antibod-
ies to VP7, suggest that VP7 is not directly
exposed at the surface of either virus particles
or ISVP, unless the outer capsid proteins are
further removed or modiﬁed
5. The enhanced
infectivity of ISVP may therefore reﬂect a
change in receptor binding mediated by VP2,
or increased efﬁciency of uncoating and expo-
sure of VP7 during the early stages of infection
and cell entry. The increased infectivity of ISVP
has been conﬁrmed in vivo by feeding adult
Culicoides [52]. The relative infectivity of intact
aggregated virus particles, ISVP and virus cores
for mammalian and insect cells, compared to
infectivity of disaggregated virus particles, is
shown in Table I.
ISVP is generated by the exposure of
intact virus particles to trypsin- or chymotryp-
sin-like proteases present in the saliva and gut
of adult Culicoides [46]. AHSV exploits the
unique environment it encounters at this stage
of its transmission to increase its chances of
infecting the insect gut wall, optimising the
likelihood of its successful vectorial transmis-
sion. Chymotrypsin-like proteases which can
cause cleavage of AHSV VP2 protein are
also present in the blood of both horses and
dogs, which may help to explain the host
range of AHSV [52].
Finally, the saliva of competent and non
competent Culicoides species appears to vary
in the amount of protease activity that it con-
tains, inﬂuencing the efﬁciency with which it
converts intact virus to ISVP. A higher degree
of VP2 cleavage occurs following incubation
with saliva from C. sonorensis than from
Culicoides nubeculosus (a non-vector species)
6,
possible due to a much lower level of trypsin in
C. nubeculosus saliva. This suggests that vector
competence may be partially determined by dif-
ferences in the protein content of theinsect’s sal-
iva, as well as by other factors.
3.2. Adaptive role of clinical signs
Following the initial infection of an equid
host, AHSV initially multiplies in the regional
lymph nodes before spreading to pulmonary
microvascular endothelial cells [44]. Prominent
pathological features of AHS (oedema, effusion
and haemorrhage) suggest loss of endothelial
cell-barrier function, in which NS3 protein
may be involved [100]. Virus is then dissemi-
nated throughout the body via the bloodstream,
infecting a range of secondary organs which
may include the lungs, spleen, other lymphoid
tissues, choroid plexus, pharynx and certain
endothelial cells [19]. Replication in these
organs produces a secondary viraemia, the
duration and titre of which depends upon host
species as well as other factors. Horses typically
demonstrate high-titre viraemia for 4–8 days,
while donkeys and zebras usually present lower
Table I. Infectiousness of modiﬁed virus particle types relative to disaggregated virus. From data in [73].
‘‘+’’ and ‘‘–’’ indicate differences of one log greater or lesser, respectively.
Virus particle type
Cell type
Disaggregated virus Aggregated virus ISVP Virus core
BHK cell line (mammalian) N/A – 0 
KC cell line (Culicoides) N/A – ++ –
5 Hutchinson I.R., The role of VP7 in initiation
of infection by bluetongue virus, Ph.D. thesis,
University of Hertfordshire, UK, 1999.
6 Darpel K.E., The bluetongue virus ‘‘ruminant
host-insect vector’’ transmission cycle; the role of
Culicoides saliva proteins in infection, Ph.D. thesis,
Royal Veterinary College, UK, 2007.
Vet. Res. (2009) 40:16 A. Wilson et al.
Page 8 of 16 (page number not for citation purpose)levels of viraemia but for much longer periods
of up to 28 days [19, 34].
Diseaseinthehostcanbeclassiﬁedaccording
to the extent and severity of clinical signs into
either acute (pulmonary), subacute (cardiac),
mixed or febrile forms [19]. The clinical form
ofdiseaseinhorsesvariesaccordingtothestrain
of virus causing the infection [45, 56, 78]. In the
acute, subacute and mixed forms of AHS the
virus is mainly localised in the cardio-vascular
and lymphatic system, while in the febrile form
of AHS the virus is concentrated in the spleen
and almost absent from the lungs and heart.
Strains isolated from the lungs of animals pre-
senting the pulmonary form of the disease have
been shown to be more virulent than isolates
fromthespleen[116],indicatingthataquasispe-
cies of viral strains with different virulence and
organ tropisms can exist within a single infected
equid host. The skin is directly involved as the
site of transmission between the insect vector
andequidhost,andviceversa.Itthereforerepre-
sents a critical organ in the infection and trans-
mission cycle of the virus (as discussed in
Sect. 2.1), and as might be expected endothelial
cells are one of the main locations in which viral
antigen can be detected [116]. The ability of a
viral strain to infect endothelial cells may there-
fore inﬂuence both the evolutionary ﬁtness of a
strain and the clinical form of disease
7.
There are a number of further ways in which
morbidity resulting from AHSV infection in the
host might directly enhance the chance of suc-
cessfultransmissiontoaCulicoidesvector.Infec-
tion by AHSV leads to increased vascular
permeability and a reduction in the number of
platelets in the blood, which could increase the
probability of viral transmission to biting arthro-
pods [42]. The development of a fever in an
infected host may also enhance transmission, as
febrile hosts may be more attractive to vector
due to their elevated temperature.Finally, severe
clinical signs in the host will reduce its ability to
defend itself against vector attack.
4. ADAPTATION FOR DISSEMINATION
WITHIN THE VECTOR
4.1. Role of nonstructural proteins in cell exit
and cytopathogenesis
Orbivirus particles leave infected cells either
by budding from the cell surface, or by lysis of
the cell [26, 53]. Insect cells become persis-
tently infected, and virus exit only occurs via
budding [26, 67], while lysis is the main mode
of virus exit from infected mammalian cells
[114]. The persistent nature of infection also
demonstrates that shut-off of host–cell protein
s y n t h e s i sd o e sn o to c c u ri nCulicoides cells.
This may help to prevent signiﬁcant levels of
cell damage and pathogenesis in the infected
insect. Virus budding is mediated by NS3
[38], and this protein is expressed at higher lev-
els in insect cells than mammalian cells [33,
38]. Suppression of NS1 protein drastically
reduces the cytopathic effects of BTV infection
in mammalian cells, suggesting that this protein
is involved in cell lysis.
For vector-borne transmission to occur efﬁ-
ciently, a virus must avoid excessive pathogen-
esis in the vector, which must remain able to
seek out new hosts for transmission to occur.
At the same time, pathogenesis in the host
may reduce its ability to notice or defend
against vector attack as discussed in the previ-
ous section, and does not carry the same selec-
tive penalty. This difference in the dominant
pathway of virus exit from infected cells is
likely to be one of the factors responsible for
the reduced pathogenic effects in the vector rel-
ative to the host, and therefore represents an
adaptation for vectorial transmission.
4.2. Effects of temperature on the replication
of AHSV
Temperature is the most important extrinsic
variable affecting the rate of orbivirus replica-
tion within the insect vector (the EIP), primarily
via its effects upon the activity of the viral RNA
polymerase but also via its effects on the ability
of the vector to modulate viral replication
within its cells [35, 41]. As temperature
decreases, virogenesis slows and eventually
7 Erasmus B.J., The pathogenesis of African horse
sickness, Proceedings of the 3rd International
Conference on Equine Infectious Diseases, 1973,
pp. 1–11.
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AHSV replication in the Culicoides vector is
approximately 15 C [115]. However, AHSV
has been shown to persist in the vector at lower
temperatures, in the absence of any detectable
viral replication, and it can resume replication
once the threshold temperature for virogenesis
is reached [109]. Adult Culicoides can also sur-
vive for relatively prolonged periods in cold
weather [48, 113], suggesting that AHSV could
potentially survive short, mild winters in small
numbers of long-lived midges. High tempera-
tures may also disrupt the development of bar-
riers to viral replication and dissemination, and
a higher level of competence is seen in midges
that are reared at high temperatures [66, 67].
Itisnowwidelyacceptedthatclimatechange
has extended the distribution of BTV further
north than ever before, both by extending the
range of C. imicola and by enhancing the poten-
tial for transmission by suitable Palaearctic vec-
tors (e.g. C. obsoletus group and C. pulicaris
group) [89]. However, the dramatic northwards
expansion of the European strain of BTV-8,
while other serotypes have so far remained
restricted to southern Europe, may indicate spe-
ciﬁc adaptation to replication in the more north-
erly ecosystem, or at cooler temperatures. This
could have important implications for the future
spread of the orbiviruses in Europe, particularly
in light of the ability of orbiviruses to exchange
segments (see Sect. 2.1).
5. ADAPTATION FOR TRANSMISSION
FROM VECTOR TO HOST
AHSV must cross the barrier represented by
the skin of the equid host twice during the
course of a single transmission cycle. Skin is
not only a mechanical barrier, but is also an
immunologically active organ capable of initiat-
ing an immune response [40, 111]. However,
arthropod saliva contains components that may
be capable of inhibiting the host immunological
response, modulating the local blood ﬂow at the
feeding site, and even promoting viral replica-
tion [12, 28, 39, 42, 103]. The epidemiological
consequences of these effects have been collec-
tively termed saliva activated transmission [92],
and are likely to inﬂuence the transmission of
orbiviruses such as AHSV by Culicoides.F o r
example, the saliva of Culicoides inhibits the
phagocytic activity of host macrophages at the
site of biting [12], and has been shown to pre-
vent blood coagulation and inﬂammation [87].
These and other effects of arthropod saliva on
the host immune response may help to explain
why infected Culicoides a r ea b l et ot r a n s m i t
virus reliably with a single bite
8,w h i l eam u c h
larger amount of infectious virus is required
for similar infection rates by needle inoculation
[7, 12, 51]. Experimental transmission of some
arboviruses via insect bite can result in greater
and longer viraemia in animalsthanthose where
injection was used [83]. Although the immuno-
modulatory effects of arthropod saliva may ben-
eﬁt the transmission of vector-borne pathogens
such as AHSV, there is thus far no evidence that
such pathogens stimulate or enhance these
effects, and they cannot therefore be said to rep-
resent an adaptation by the pathogen to
transmission.
The introduction of orbiviruses into the skin
of a naı ¨ve host is rapidly accompanied by a
high level of viral replication and infection of
both leukocytes and the microvascular epithe-
lium of skin capillaries
9. The recruitment of cel-
lular components of the host immune system,
as part of a hypersensitivity response to the
Culicoides saliva proteins at the biting site,
increases the likelihood of their infection and
may play a part in the early stages of infection
and dissemination within the mammalian host.
The ability to infect cells attracted by this sen-
sitivity response can therefore be regarded as
an adaptation by the virus in order to enhance
its transmission. It has also been suggested that
local replication in the skin of an infected host
may facilitate non-systemic transmission of
viruses such as BTV or AHSV
9, as demon-
strated for other pathogens such as tick-borne
8 O’Connell L., Entomological aspects of orbivi-
ruses by Culicoides biting midges, Ph.D. thesis,
University of Bristol, UK, 2002.
9 Darpel K.E., The bluetongue virus ‘‘ruminant
host-insect vector’’ transmission cycle; the role of
Culicoides saliva proteins in infection, Ph.D. thesis,
Royal Veterinary College, UK, 2007.
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feeders and may feed in large numbers on a sin-
gle animal, which would increase the efﬁciency
of this transmission route. However, there is no
evidence so far of direct virus transmission
between co-feeding Culicoides.
6. ADAPTATION TO PERIODS
OF VECTOR ABSENCE
Throughout much of the range of AHSV, the
climate is suitable for adult Culicoides to
remain active throughout the year. However,
in some areas, conditions can be unsuitable dur-
ing parts of the year for the emergence or activ-
ity of adult Culicoides, or temperatures may be
too low for the virus to replicate in the vector.
Despite these interruptions in normal transmis-
sion, AHSV and BTV are still able to persist
for long periods during adverse climatic condi-
tions without the observation of new cases. This
phenomenon is termed ‘‘overwintering’’. In
some cases these absences can last for up to
11½ months and have resulted in false assump-
tions that an outbreak has ended [3, 25].
A number of different mechanisms could
potentially be involved in orbivirus overwinter-
ing [113]. Persistent or chronic AHSV infection
in horses is considered unlikely, as viraemia is
short and mortality rates frequently exceed
90%. However, zebras display a detectable vira-
emia for up to 40 days post-infection, while
virus could be recovered from tissues and cells
for up to 48 days [6]. Donkeys, meanwhile, ﬁt
between these two extremes, typically display-
ing a viraemia for up to 4 weeks and a mortality
rate of around 10% [19]. There is a possibility
that latently-infected animals may represent a
mechanism of overwintering, following the dis-
covery of a similar mechanism in the case of
BTV-infected sheep [101], although there is
currently no evidence that AHSV has adapted
to seasonal vector absence in a similar way.
Other routes such as transplacental transmission
have been implicated for BTV, but the rele-
vance of these routes (if any) to the overwinter-
ing of AHSV remains unknown. Finally,
although it would represent a highly advanta-
geous adaptation to the seasonal absence of
adult vectors, there is no evidence that vertical
transmission of AHSV is likely to occur in
the insect vector, with studies suggesting that
pores in the membrane surrounding the devel-
oping egg mechanically prevent intact virus
particles from entering it [80], while allowing
fragments of RNA to pass through [110]. To
summarise, few of the possible mechanisms
for orbivirus overwintering have been conclu-
sively demonstrated, and many are highly spec-
ulative. It is also possible that the mechanisms
responsible vary by region or virus strain.
7. POTENTIAL EFFECTS OF TISSUE
CULTURE ATTENUATION
ON EPIDEMIOLOGY
The repeated passage of a virus through ver-
tebrate cell lines (tissue culture attenuation),
which is a procedure frequently undertaken in
theproductionofliveattenuatedvaccines,might
be expected to reduce or remove its ability to
replicate in vector insects. However, the work
of Paweska et al. [86], when working with
AHSV serotypes 1, 2, 3, 4, 6, 7 and 8, has
shownthatsuchattenuationdoes notnecessarily
eliminateavirus’scapabilitytoinfectCulicoides
vectors, and more recent work [107] suggests
that tissue culture attenuation of AHSV might
even lead to enhanced replication in vectors.
Other changes may also be conferred upon
viruses manipulated in this way, and Gibbs
et al. [27] have shown that tissue culture attenu-
ated strains of the related BTV are able to be
transmitted transplacentally from dam to foetus
in the vertebrate host. As far as we are aware
there are no experimental data to indicate
whether tissue culture passaged AHSV can, or
cannot be transmitted transplacentally.
8. CONCLUSIONS
Vector-borne transmission is a highly com-
plex process. It requires virus to be located in
the peripheral blood vessels or skin of the ver-
tebrate host, to tolerate the proteolytic environ-
ment of the arthropod gut, and to be able to
spread from the gut of the arthropod to the sal-
ivary glands, while at the same time minimising
the damage caused to the arthropod vector.
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transmission between equid hosts by Culicoides
midges in the apparent absence of alternative
transmission mechanisms. The AHSV particle
can be modiﬁed by pH or proteases in its imme-
diate environment, and appears to have adapted
t om a k eu s eo ft h e s ec h a n g e sd u r i n gt r a n s m i s -
sion. AHSV also appears to manipulate the
extent of pathogenesis in the host and vector
to maximise the likelihood of its successful
transmission. However, speculation upon sev-
eral potential adaptations for successful vecto-
rial transmission is based upon research on
related viruses such as BTV, and further direct
study of AHSV is required.
Several aspects of the epidemiology of
AHSV indicate that it represents a signiﬁcant
risk to Europe and North America. Although
it is currently restricted to sub-Saharan Africa,
it has expanded beyond this core region on sev-
eral occasions, demonstrating a capacity to per-
sist in these regions for several years [4, 64].
This suggests that the geographical area poten-
tially suitable for AHSV transmission is consid-
erably greater than that in which it is currently
found. The recent expansion of BTVinto north-
ern Europe also supports this conclusion. Both
the 1965 and 1987 AHS outbreaks were traced
to the importation of sub-clinically infected
equids[47,57,88]suggestingthatanimalmove-
ments represent an important route of AHSV
introduction into new regions. This risk could
be reduced by strict adherence to appropriate
international trade regulations. Adaptations
whichreducethefrequencyorseverityofclinical
signscouldparadoxicallyincreasetheglobalrisk
from the disease by making the detection of
infectedindividualsmoredifﬁcultandaccidental
introduction more likely. Like BTV, AHSV is
capable of persisting in an area for long periods
of time without the appearance of new cases, a
phenomenon termed ‘‘overwintering’’. This is
likely to complicate the eradication of AHSV
outbreaks, as well as verifying the success of
eradication programmes.
In order to be capable of accurately assessing
riskfromAHSV,weneedtofurtherimproveour
understanding of how variations in the virus can
alteritscapacitytoinfectandcauseclinicalsigns
indifferenthostspecies,aswellasinﬂuencingits
transmission between Culicoides vectors and
equid hosts in different ecosystems and under
different environmental conditions.
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